Correlation Between Revolution Medicines and Pliant Therapeutics
Can any of the company-specific risk be diversified away by investing in both Revolution Medicines and Pliant Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Revolution Medicines and Pliant Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Revolution Medicines and Pliant Therapeutics, you can compare the effects of market volatilities on Revolution Medicines and Pliant Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Revolution Medicines with a short position of Pliant Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Revolution Medicines and Pliant Therapeutics.
Diversification Opportunities for Revolution Medicines and Pliant Therapeutics
0.48 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Revolution and Pliant is 0.48. Overlapping area represents the amount of risk that can be diversified away by holding Revolution Medicines and Pliant Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pliant Therapeutics and Revolution Medicines is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Revolution Medicines are associated (or correlated) with Pliant Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pliant Therapeutics has no effect on the direction of Revolution Medicines i.e., Revolution Medicines and Pliant Therapeutics go up and down completely randomly.
Pair Corralation between Revolution Medicines and Pliant Therapeutics
Given the investment horizon of 90 days Revolution Medicines is expected to generate 0.86 times more return on investment than Pliant Therapeutics. However, Revolution Medicines is 1.16 times less risky than Pliant Therapeutics. It trades about 0.33 of its potential returns per unit of risk. Pliant Therapeutics is currently generating about -0.14 per unit of risk. If you would invest 4,775 in Revolution Medicines on August 27, 2024 and sell it today you would earn a total of 900.00 from holding Revolution Medicines or generate 18.85% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Revolution Medicines vs. Pliant Therapeutics
Performance |
| Timeline |
| Revolution Medicines |
| Pliant Therapeutics |
Revolution Medicines and Pliant Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Revolution Medicines and Pliant Therapeutics
The main advantage of trading using opposite Revolution Medicines and Pliant Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Revolution Medicines position performs unexpectedly, Pliant Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pliant Therapeutics will offset losses from the drop in Pliant Therapeutics' long position.| Revolution Medicines vs. Blueprint Medicines Corp | Revolution Medicines vs. Sana Biotechnology | Revolution Medicines vs. Kymera Therapeutics | Revolution Medicines vs. Monte Rosa Therapeutics |
| Pliant Therapeutics vs. Eliem Therapeutics | Pliant Therapeutics vs. HCW Biologics | Pliant Therapeutics vs. Scpharmaceuticals | Pliant Therapeutics vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Other Complementary Tools
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |